Skip to main content
OpenTrials

Clinical trial condition

Carcinoma

Explore clinical trials studying Carcinoma. Study availability and eligibility vary by location and protocol.

8,758 public trials 2,076 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma trial results

Active, Not Recruiting

Study of Zanzalintinib (XL092) + Pembrolizumab vs Pembrolizumab in Subjects With PD-L1 Positive Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

NCT06082167

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +6 more
Locations
  • Exelixis Clinical Site #2 Fullerton, California, United States
  • Exelixis Clinical Site #1 Orange City, Florida, United States
  • Exelixis Clinical Site #163 Tampa, Florida, United States
  • Exelixis Clinical Site #123 Athens, Georgia, United States
View all 168 locations
View Trial Details
Active, Not Recruiting

Study of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors

NCT03170960

Conditions
Adenocarcinoma, Adnexal Diseases, Breast Diseases, +68 more
Locations
  • Exelixis Clinical Site #53 Gilbert, Arizona, United States
  • Exelixis Clinical Site #18 Phoenix, Arizona, United States
  • Exelixis Clinical Site #1 Duarte, California, United States
  • Exelixis Clinical Site #20 La Jolla, California, United States
View all 124 locations
View Trial Details
Active, Not Recruiting

A Study of SNS-101 (Anti VISTA) Monotherapy and in Combination With Cemiplimab in Patients With Advanced Solid Tumors

NCT05864144

Conditions
Adenocarcinoma, Adnexal Diseases, Advanced Cancer, +101 more
Locations
  • UCLA Hematology/Oncology Los Angeles, California, United States
  • University of Colorado Cancer Center - Anschutz Medical Aurora, Colorado, United States
  • Norton Healthcare Louisville, Kentucky, United States
  • Henry Ford Cancer Detroit, Michigan, United States
View Trial Details
Active, Not Recruiting

Study Assessing The "Best of" Radiotherapy vs the "Best of" Surgery in Patients With Oropharyngeal Carcinoma

NCT02984410

Conditions
Carcinoma, Carcinoma, Squamous Cell, Head and Neck Neoplasms, +14 more
Locations
  • CHU-UCL Namur - CHU Mont Godinne Namur, Yvoir, Belgium
  • Cliniques Universitaires Saint-Luc Brussels, Belgium
  • Institut Jules Bordet-Hopital Universitaire ULB Brussels, Belgium
  • U.Z. Leuven - Campus Gasthuisberg Leuven, Belgium
View all 32 locations
View Trial Details
Active, Not Recruiting

Study to Evaluate Adverse Events, and Change in Disease Activity, When Intravenously (IV) Infused With Livmoniplimab in Combination With IV Infused Budigalimab in Adult Participants With Hepatocellular Carcinoma (HCC)

NCT05822752

Conditions
Adenocarcinoma, Carcinoma, Carcinoma, Hepatocellular, +9 more
Locations
  • Arizona Oncology Associates, PC - NAHOA Prescott Valley /ID# 254313 Prescott Valley, Arizona, United States
  • Highlands Oncology Group, PA /ID# 253158 Springdale, Arkansas, United States
  • University of California, Los Angeles /ID# 253292 Los Angeles, California, United States
  • UC Irvine /ID# 252707 Orange, California, United States
View all 59 locations
View Trial Details
Active, Not Recruiting

Study to Evaluate Adverse Events and Change in Disease Activity When Intravenously (IV) Infused Livmoniplimab is Used in Combination With IV Infused Budigalimab in Adult Participants With Urothelial Carcinoma (UC)

NCT06632951

Conditions
Carcinoma, Carcinoma, Transitional Cell, Neoplasms, +3 more
Locations
  • Highlands Oncology Group - Springdale /ID# 270290 Springdale, Arkansas, United States
  • University of California San Francisco - Mission Bay /ID# 270289 San Francisco, California, United States
  • Yale University School of Medicine /ID# 270449 New Haven, Connecticut, United States
  • Medical Oncology Hematology Consultants /ID# 271347 Newark, Delaware, United States
View all 37 locations
View Trial Details

Related conditions